Atlas Trials

Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials

Clinical trial NCT06612632 · RECRUITING

Trial details

NCT number
NCT06612632
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2024-05-24
Primary completion
2026-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.